Health Sciences Library & Informatics Center
MSC09 5100
1 University of New Mexico
Albuquerque, NM 87131-0001

Find Faculty at UNM Health Sciences Center

Cheryl L Willman, MD


Contact Information:
1 University of New Mexico
MSC 08 4630
CRF 101
Albuquerque NM 87131


SOM Pathology Department


Big questions:

  • What are the molecular alterations that lead to leukemia?
  • How will DNA arrays and proteomics improve our understanding of leukemogenesis?
Model systems:
  • Human leukemia (POG, SWOG tissue banks)
  • Gene arrays
  • Molecular Biology

  • Genomics and Genetics of Acute Leukemia; Genomics for Molecular Classification, Risk Assesment, and Target Identification
  • Molecular Hematology: Molecular and Cellular Biology of Normal and Leukemic Myeloid Cells

* Cheson, B.D., Bennett, J.M., Kopecky, K.J., Buchner, T., Willman, C.L., 2003, Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia: J Clin Oncol 21(24) p.4642-4649

* Stirewalt, D.L., Appelbaum, F.R., Willman, C.L., Zager, R.A., Banker, D.E., 2003, Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression: Leukemia Research 27(2), p.133-145

* Carroll, W.L., Bhojwami, D., Min, D.J., Raetz, E., Relling, M., Davies, S., Downing, J.R., Willman, C.L., Reed, J.C., 2003, Pediatric acute lymphoblastic leukemia: Hematology p.102-131

* Willman, CL. Targeted AML therapy: new biologic paradigms and therapeutic opportunities. 2001. State of the Art Mini-Review. Leukemia 15:690-694.

* List AF, Kopecky KJ, Willman CL, Spier C, Dorr R, Chen IM, Karanes C, Hynes H, Appelbaum. 2001. Benefit of cyclosporine modulation of anthracycline resistance in patients with poor-risk acute myeloid leukemia. Blood 98 (12): 3212-3220.

* Garrido SM, Appelbaum FR, Willman CL, and Banker DE. 2001. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). Experimental Hematology 29:448-457.